Get it on Google Play

Moderna's Cancer Vaccine Breakthrough & Why Uber Could Win the Robotaxi War

Moderna's Cancer Vaccine Breakthrough & Why Uber Could Win the Robotaxi War

Author: MyWallSt August 27, 2026 Duration: 48:54
Stock Club
BusinessInvesting

Moderna (NASDAQ:MRNA) is back in the headlines after phase three success for what's being called a cancer vaccine, built on the same mRNA technology that powered its Covid vaccine. We discuss just how significant it is that this treatment has gotten this far in trials, why the pandemic accelerated mRNA research faster than anyone expected, and why the commercial realities of personalized medicine, similar to the challenges facing CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals (NASDAQ:VRTX) with their multi million dollar sickle cell treatment, could complicate scalability even if the science works.

We make the case for why investing in a company trying to cure previously unsolvable diseases is worth serious consideration for stock investors, even beyond the pure economics, and why crossing a scientific milestone like this can open the floodgates for the rest of the biotech industry.

Then we shift to Uber (NYSE:UBER) and the case for why the robotaxi race may not be as simple as Waymo good, Uber bad. Rather than spending billions building its own autonomous vehicle fleet, Uber is positioning itself as the aggregator that Waymo, Zoox, Baidu and a growing list of AV players plug into. We break down CEO Dara Khosrowshahi's argument that the highest utilization operator will have the lowest cost of capital, and count the wave of robotaxi partnerships announced over just the last four months.

We close out on why this is not a simple binary bet, how Uber's ride hailing and delivery business has quietly become far more profitable in recent years, and why autonomous driving commoditization could actually favor Uber's asset light model as the technology scales globally.

Stocks mentioned:

  • Moderna Inc (NASDAQ:MRNA)
  • CRISPR Therapeutics AG (NASDAQ:CRSP)
  • Vertex Pharmaceuticals Inc (NASDAQ:VRTX)
  • Uber Technologies Inc (NYSE:UBER)
  • Alphabet Inc / Waymo (NASDAQ:GOOGL)
  • Tesla Inc (NASDAQ:TSLA)
  • Amazon.com Inc / Zoox (NASDAQ:AMZN)
  • Lyft Inc (NASDAQ:LYFT)

#StockClub #MyWallst #ModernaStock #UberStock #CancerVaccine #RobotaxiStocks #StocksToBuy


Each week on Stock Club, the team from MyWallSt gathers to break down the movements and ideas shaping the market. This isn't about hype or frantic trading tips; it's a grounded conversation focused on understanding how investing actually works. You'll hear them analyze specific stock news and discuss the strategies behind building lasting wealth, all with the aim of making you a more thoughtful and confident investor. The discussion in this podcast naturally evolves from the week's most significant events, offering clarity on complex financial stories without relying on jargon. Tuning in feels like being part of a straightforward, informed discussion where the priority is long-term perspective over short-term noise. For anyone looking to deepen their grasp of the business and investing landscape, Stock Club provides a consistent, reliable space to learn. It’s the regular check-in that helps demystify the market's shifts, emphasizing education and insight as the true foundations for success. You can find Stock Club wherever you listen to podcasts.
Author: Language: English Episodes: 50

Official website RSS
instagramyoutubetiktoklinkedinspotify
Stock Club
Podcast Episodes
#308: The Best and Worst Business Pivots [not-audio_url] [/not-audio_url]

Duration: 46:15
In light of Allbirds’ (NASDAQ: BIRD) head-scratching transition to an AI compute infrastructure company, Mike and Emmet break down some of the market’s best and worst business pivots.In simple terms, a pivot is when a bu…
#307: Is SpaceX’s IPO a Buy? [not-audio_url] [/not-audio_url]

Duration: 50:49
This week, we’re discussing one of the most significant IPOs of all time: SpaceX.While space travel began as a government-led effort, over the past few decades it has increasingly become the domain of the private sector.…
#306: Ireland’s New Investment Scheme Explained [not-audio_url] [/not-audio_url]

Duration: 38:09
The day we’ve been hoping for is finally here. The Irish government has announced a new investing scheme to provide people in Ireland with an easy, tax-efficient way to access the markets. There are hundreds of billions…
Stock Red Flags to Avoid Before They Destroy Your Portfolio [not-audio_url] [/not-audio_url]

Duration: 47:17
We normally talk about the characteristics we love to find in stocks. But this week, we bring you all the things we hate. We’ve all gotten caught in a hype cycle or seen an investment thesis degrade, so having a list of…
2 Australian (ASX) Stocks to Buy Right Now [not-audio_url] [/not-audio_url]

Duration: 40:01
Investor Down Under — g’day. We’ve long loved hunting for underappreciated stocks abroad, and over the years we’ve realized Australia is a particularly great place to find them. With its investing culture on the rise, th…
#303: The AI Stocks No One is Talking About: Biotech Boom [not-audio_url] [/not-audio_url]

Duration: 47:38
This week, Emmet and Mike are digging into one of the hottest trends of our futuristic world: human longevity. We’ve all seen Bryan Johnson on our social feeds, but the business of living longer is more than just a meme.…
#302: The One Metric You Need to Find Multibagger Stocks [not-audio_url] [/not-audio_url]

Duration: 45:29
We’ve pitched you businesses and described graphs, but this week Mike and Emmet put the power in your hands and teach you how to find multibagger stocks. And it can be as simple as one metric: insider ownership.Inspired…
#301: The 6 Best Dividend Stocks to Buy [not-audio_url] [/not-audio_url]

Duration: 54:02
This week, we’re heading to safer shores — trading moonshots for mailboxes — and bringing you Emmet and Mike’s favorite dividend stocks.We’re growth investors at heart and would usually rather see smart R&D spending than…

«12345»